- Home
- UFCS vs HROW Comparison
UFCS vs HROW Comparison
Compare UFCS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFCS
- HROW
- Stock Information
- Founded
- UFCS 1946
- HROW 1998
- Country
- UFCS United States
- HROW United States
- Employees
- UFCS N/A
- HROW N/A
- Industry
- UFCS Property-Casualty Insurers
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- UFCS Finance
- HROW Health Care
- Exchange
- UFCS Nasdaq
- HROW Nasdaq
- Market Cap
- UFCS 515.3M
- HROW 609.3M
- IPO Year
- UFCS N/A
- HROW N/A
- Fundamental
- Price
- UFCS $20.07
- HROW $37.98
- Analyst Decision
- UFCS Sell
- HROW Strong Buy
- Analyst Count
- UFCS 1
- HROW 4
- Target Price
- UFCS $19.00
- HROW $42.50
- AVG Volume (30 Days)
- UFCS 115.5K
- HROW 705.0K
- Earning Date
- UFCS 10-30-2024
- HROW 08-07-2024
- Dividend Yield
- UFCS 3.19%
- HROW N/A
- EPS Growth
- UFCS N/A
- HROW N/A
- EPS
- UFCS 1.44
- HROW N/A
- Revenue
- UFCS $1,158,442,000.00
- HROW $154,146,000.00
- Revenue This Year
- UFCS N/A
- HROW $52.51
- Revenue Next Year
- UFCS $9.19
- HROW $41.21
- P/E Ratio
- UFCS $13.93
- HROW N/A
- Revenue Growth
- UFCS 10.34
- HROW 50.06
- 52 Week Low
- UFCS $18.04
- HROW $7.60
- 52 Week High
- UFCS $25.55
- HROW $44.80
- Technical
- Relative Strength Index (RSI)
- UFCS 45.32
- HROW 55.64
- Support Level
- UFCS $20.09
- HROW $38.52
- Resistance Level
- UFCS $20.66
- HROW $41.16
- Average True Range (ATR)
- UFCS 0.38
- HROW 2.06
- MACD
- UFCS 0.07
- HROW -0.81
- Stochastic Oscillator
- UFCS 46.27
- HROW 3.40
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.